BOCIC(SH:601696) Xin Lang Cai Jing·2025-10-16 02:14Group 1 - Yifang Biotechnology's stock increased by 5.25%, reaching 28.25 CNY per share, with a trading volume of 204 million CNY and a turnover rate of 1.75%, resulting in a total market capitalization of 16.338 billion CNY [1] - Yifang Biotechnology, established on January 11, 2013, and listed on July 25, 2022, focuses on the research, production, and sales of innovative drugs, with 100% of its main business revenue coming from technology licensing and cooperation [1] Group 2 - According to data, a fund under Bank of China Securities holds a significant position in Yifang Biotechnology, with the Bank of China Health Industry Mixed Fund (002938) reducing its holdings by 260,000 shares in the second quarter, now holding 450,000 shares, which constitutes 9.35% of the fund's net value, making it the largest holding [2] - The Bank of China Health Industry Mixed Fund (002938) was established on September 7, 2016, with a current size of 158 million CNY, achieving a year-to-date return of 42.56%, ranking 1461 out of 8161 in its category, and a one-year return of 33.7%, ranking 2675 out of 8021 [2]